ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steinke, K.
Right arrow Articles by Morris, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steinke, K.
Right arrow Articles by Morris, D. L.
Related Collections
Right arrow Lung - cancer
Right arrow Minimally invasive surgery
Interactive Cardiovascular and Thoracic Surgery 2:462-465(2003)
© 2003 European Association of Cardio-Thoracic Surgery


Negative results - Pulmonary

Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed?

Karin Steinkea,*, Julie Kinga, Derek Glennb and David L. Morrisa

a Department of Surgery, UNSW, The St. George Hospital, Pitney Building, Gray Street, Sydney, NSW 2217, Australia
b Department of Radiology, UNSW, The St. George Hospital, Sydney, NSW 2217, Australia

* Corresponding author. Tel.: +61-2-9350-2070; fax: +61-2-9350-3997
ksteinke{at}uhbs.ch

Objective: To alert clinicians of the underreported complication of intraparenchymal lung hemorrhage during percutaneous radiofrequency ablation (RFA) of primary and secondary pulmonary malignancies. Methods: Of 101 RF ablations performed in 46 patients, 81 were retrospectively assessed for periprocedural intrapulmonary bleeding. The data was compared with the literature for this minimally invasive interventional treatment as well as with the reported frequency of lung hemorrhage during diagnostic lung biopsies. Results: Our incidence of hemorrhage during percutaneous lung RFA was 5.9%. The reported frequency in the scarce literature available is less than 1%. Data in the literature for percutaneous biopsy-related intraparenchymal hemorrhage ranges from 1.4% for fine-needle aspirations to 29% for core biopsies. Conclusion: Intraparenchymal lung hemorrhage during percutaneous RFA of primary and secondary pulmonary malignancies is similar to reported lung hemorrhage for diagnostic core biopsies. We believe this complication to be underreported in the literature.

Key Words: Percutaneous; Radiofrequency ablation; Lung; Tumor; Hemorrhage; Complication







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 European Association for Cardio-thoracic Surgery